Skip to main content
. 2013 Mar;87(6):3295–3304. doi: 10.1128/JVI.01621-12

Fig 6.

Fig 6

Antiviral activity of dendrimeric peptide SB105-A10. Huh7 cells were treated with increasing concentrations of the dendrimer SB105-A10 or the SB104 negative control 1 h prior to and during the infection with concentrated HIV pseudotypes bearing EBOV, MARV, or Lassa virus envelope glycoproteins. Results are expressed as percentages of inhibition and represent the means ± SD for duplicate wells. The results are representative of at least three different experiments.